000			01541 a2200409 4500
005			20250515233852.0
264		0	_c20110224
008			201102s 0 0 eng d
022			_a1476-5608
024	7		_a10.1038/pcan.2010.26 _2doi
040			_aNLM _beng _cNLM
100	1		_aChoi, H Y
245	0	0	_aCurcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells. _h[electronic resource]
260			_bProstate cancer and prostatic diseases _cDec 2010
300			_a343-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xmetabolism
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Nucleus _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCurcumin _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aProstatic Neoplasms _xmetabolism
650	0	4	_aProtein Binding _xdrug effects
650	0	4	_aReceptors, Androgen _xmetabolism
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aWnt1 Protein _xmetabolism
650	0	4	_abeta Catenin _xmetabolism
700	1		_aLim, J E
700	1		_aHong, J H
773	0		_tProstate cancer and prostatic diseases _gvol. 13 _gno. 4 _gp. 343-9
856	4	0	_uhttps://doi.org/10.1038/pcan.2010.26 _zAvailable from publisher's website
999			_c20019126 _d20019126